In a rat model of ischemia/reperfusion injury, PCSK9 inhibitor was shown to reduce cardiac arrhythmias, suggesting potential cardioprotective effects beyond lipid-lowering [32]. The gene discussed is PCSK9; the disease is chronic obstructive pulmonary disease.